# NVO — Novo Nordisk A/S Common Stock: congressional trades

> Members of Congress' disclosed trades in NVO (STOCK Act). Corporate-insider (Form 4) activity is a separate dataset: https://www.fatcatwatch.com/api/v1/insiders/NVO. Data as of 2026-10-23T17:16:03Z.

Dashboard: https://www.fatcatwatch.com/tickers/NVO · JSON: https://www.fatcatwatch.com/api/v1/tickers/NVO

## Totals

- Members: 3 (2 bought, 1 sold)
- Trades: 4 (2 buys, 2 sells); last trade date 2026-09-10
- Disclosed volume: $18,004–$95,000; estimated midpoint ≈ $57k (an estimate from bracket midpoints, not a disclosed figure)

## Members

| Member | Party | Trades | Buys | Sells | Disclosed range | Est. midpoint |
| --- | --- | --- | --- | --- | --- | --- |
| [Alan Armstrong](https://www.fatcatwatch.com/members/alan-armstrong-a000383) | Senate · R, OK | 1 | 1 | 0 | $15,001–$50,000 | ≈$33k (est.) |
| [Kevin Hern](https://www.fatcatwatch.com/members/kevin-hern-h001082) | House · R, OK-1 | 2 | 0 | 2 | $2,002–$30,000 | ≈$16k (est.) |
| [Scott Franklin](https://www.fatcatwatch.com/members/scott-franklin-f000472) | House · R, FL-18 | 1 | 1 | 0 | $1,001–$15,000 | ≈$8,001 (est.) |

## Recent trades (4 of 4)

| Trade date | Filed | Delay (days) | Member | Action | Asset | Owner | Amount disclosed | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-09-10 | 2026-09-25 | 15 | [Kevin Hern](https://www.fatcatwatch.com/members/kevin-hern-h001082) | Sell | Novo Nordisk A/S Common Stock | self | $1,001–$15,000 (bracket) | [source](https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035491.pdf) |
| 2026-08-31 | 2026-09-25 | 25 | [Kevin Hern](https://www.fatcatwatch.com/members/kevin-hern-h001082) | Sell (partial) | Novo Nordisk A/S Common Stock | self | $1,001–$15,000 (bracket) | [source](https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035491.pdf) |
| 2026-08-26 | 2026-09-17 | 22 | [Scott Franklin](https://www.fatcatwatch.com/members/scott-franklin-f000472) | Buy | Novo Nordisk A/S Common Stock | self | $1,001–$15,000 (bracket) | [source](https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035450.pdf) |
| 2026-03-30 | 2026-07-21 | 113 (late) | [Alan Armstrong](https://www.fatcatwatch.com/members/alan-armstrong-a000383) | Buy | Novo Nordisk A/S Common Stock | self | $15,001–$50,000 (bracket) | [source](https://efdsearch.senate.gov/search/view/ptr/fda235b3-bad7-4637-8fa1-053f354d929c/) |

## How to quote this

- Congressional amounts are STOCK Act brackets (e.g. $1,001–$15,000), not figures: quote the range, never a single number.
- Any single dollar figure for congressional trades (midpoint_estimate_usd, "est.") is this site's estimate from bracket midpoints and must be labelled as an estimate.
- Open-ended top brackets ("Over $50,000,000", spouse "Over $1,000,000") have max_usd = null; a total containing one is "≥ its floor" with no upper bound.
- amount.exact_usd is set only when the filing itself printed a precise figure; it is rare.
- Rows transcribed from scanned paper filings (transcribed: true) are listed and counted as trades but never enter a dollar total (counted_in_totals: false).
- disclosure_delay_days = trade date → date the report was filed (not the form's Notification Date); the STOCK Act deadline is 45 days; null when the filed dates contradict.

Full rules: https://www.fatcatwatch.com/llms-full.txt · Methodology: https://www.fatcatwatch.com/methodology